Feasibility of group voice therapy for individuals with Parkinson's disease

Journal of Communication Disorders

Volumn 44, Issue 6, 2011, Pages 719-732

  Searl, Jeff ^a   Wilson, Kristel ^a   Haring, Karen ^a   Dietsch, Angela ^a   Lyons, Kelly ^b   Pahwa, Rajesh ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Group therapy; Parkinson's disease; Voice therapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; GROUP VOICE THERAPY; HUMAN; INTERVENTION STUDY; LOUDNESS; MALE; PARKINSON DISEASE; PHONATION; QUALITY OF LIFE; READING; SELF CONCEPT; SPEECH ANALYSIS; SPEECH THERAPY; TASK PERFORMANCE; TREATMENT OUTCOME; VOICE; VOICE HANDICAP SCORE; VOICE INTENSITY;

ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; PARKINSON DISEASE; PATIENT SATISFACTION; PSYCHOTHERAPY, GROUP; SPEECH THERAPY; TREATMENT OUTCOME; VOICE DISORDERS; VOICE TRAINING;

EID: 80755135537     PISSN: 00219924     EISSN: 18737994     Source Type: Journal    
DOI: 10.1016/j.jcomdis.2011.05.001     Document Type: Article

References (30)

1. Baumgartner C., Sapir S., Ramig L. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson's disease. Journal of Voice 2001, 15(1):105-114.
2. de Angelis E., Mourao L., Ferraz H., Behlau M., Pontes, Andrade L. Effect of voice rehabilitation on oral communication of Parkinson's disease patients. Acta Neurologica Scandinavica 1997, 96:199-205.
3. De Letter M., Santens P., De Bodt M., Boon P., Van Borsel J. Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurology 2006, 106:19-22.
4. Elman R.J., Bernstein-Ellis E. Psychosocial aspects of group communication treatment. Preliminary findings. Seminars in Speech and Language 1999, 20:65-71.
5. Downie A., Low J., Lindsay D. Speech disorder in Parkinsonism: Usefulness of delayed auditory feedback in selected cases. British Journal of Communication Disorders 1981, 16:135-139.
6. Erb E. Improving speech in Parkinson's disease. American Journal of Nursing 1973, 73:1910-1911.
7. Fox C., Ramig L., Ciucci M., Sapir S., McFarlnad D., Farley B. The science and practice of LSVT/LOUD: Neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Seminars in Speech and Language 2006, 27:283-299.
8. Goldblum G., Mulder M., von Gruenewaldt A. An examination of the impact of participation in a conversation group for individuals with a closed head injury. The South African Journal of Communication Disorders 2001, 48:3-20.
9. Hartelius L., Stevens P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: A survey. Folia Phoniatrica Logopedica 1994, 46(1):9-17.
10. Howell S., Tripoliti E., Pring T. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: A feasibility study. International Journal of Language and Communication Disorders 2009, 44(3):287-300.
11. Kompoliti K., Wang Q., Goetz C., Leurgans S., Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 2000, 54:458-462.
12. Logemman J.A., Fisher H.B., Boshes B., Blonskey E.R. Frequency and cooccurences of vocal tract dysfunctions in the speech of a large sample of Parkison patients. Journal of Speech and Hearing Disorders 1978, 43(1):47-57.
13. Quaglieri C.E., Celesia G.G. Effect of thalamotomy and levodopa therapy on the speech of Parkinson patients. European Neurology 1977, 15:34-39.
14. Ramig L., Countryman S., O'Brien C., Hoehn M., Thompson L. Intensive speech treatment for patients with Parkinson's disease. Short and long-term comparison of two techniques. Neurology 1996, 47:1496-1504.
15. Ramig L., Dromey C. Aerodynamic mechanism underlying treatment-related changes in vocal intensity in patients with Parkinson's disease. Journal of Speech and Hearing Research 1996, 39(4):798-807.
16. Ramig L., Fox C., Sapir R. Parkinson's disease: Speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Seminars in Speech and Language 2004, 25(2):169-180.
17. Ramig L., Sapir S., Fox C., Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: A comparison with untreated patients and normal aged-matched controls. Movement Disorders 2001, 16:79-83.
18. Robertson S.J., Thomson F. Speech therapy in Parkinson's disease: A study of the efficacy and long term effects of intensive treatment. British Journal of Disorders of Communication 1984, 19:213-224.
19. Sapir R., Spielman J.L., Ramig L., Story B.H., Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual findings. Journal of Speech, Language and Hearing Research 2007, 50(4):899-912.
20. Sarno M. Speech impairment in Parkinson's disease. Archives of Physical Medicine and Rehabilitation 1968, 49:269-275.
21. Skodda, A., Flasskamp, A., & Schlegel, U. (2010). Instability of syllable repetition in Parkinson's disease - Influence of levodopa and deep brain stimulation. Movement Disorders (EPub ahead of print, 10 November 2010).
22. Spielman J., Ramig L., Mahler L., Halpern A., Gavin W. Effects of an extended version of the Lee Silverman Voice Treatment on voice and speech in Parkinson's disease. American Journal of Speech-Language Pathology 2007, 16:95-107.
23. Sullivan M.D., Brune P.J., Beukelman D.R. Maintenance of speech changes following group treatment for hypokinetic dysarthria of Parkinson's disease. Disorders of motor speech: Assessment, treatment and clinical characterization 1996, 287-310. Brookes, Baltimore. D.A. Robin, K.M. Yorkston, D.R. Beukelman (Eds.).
24. Tindall L., Huebner R., Stemple J., Kleinert H. Videophone-delivered voice therapy: A comparative analysis of outcomes to traditional delivery for adults with Parkinson's disease. Telemedicine and e-Health 2008, 14(10):1070-1077.
25. Trail M., Fox C., Ramig L., Sapir S., Howard J., Lai E. Speech treatment for people with Parkinson's disease. Neurorehabilitation 2005, 20:205-221.
26. Tripoliti E., Zrino L., Martinez-Torres I., Frost E., Pinto S., Foltynie T., et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson's disease. Neurology 2011, 76:80-86.
27. Williams D.F., Dugan P.M. Administering stuttering modification therapy in school settings. Seminars in Speech and Language 2002, 23:187-194.
28. Winholtz W.S., Titze I.R. Conversion of a head-mounted microphone signal into calibrated SPL units. Journal of Voice 1997, 11:417-421.
29. Wohlert A.B. Service delivery variables and outcomes of treatment for hypokinetic dysarthria in Parkinson disease. Movement Disorders 2004, 12:235-239.
30. Yorkston K., Miller R., Strand E. Management of speech and swallowing disorders in degenerative disease 1995, Pro-ed, Austin, TX.